B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
Mielants
H
H
Veys
E M
EM
D000380:Agranulocytosis / Q000139:chemically induced*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D015796:HLA-B27 Antigen / Q000032:analysis*; D006801:Humans; D007978:Levamisole / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male
D018501:Antirheumatic Agents; D015796:HLA-B27 Antigen; D007978:Levamisole